1. Home
  2. FMY vs NEPH Comparison

FMY vs NEPH Comparison

Compare FMY & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust Motgage Income Fund of Beneficial Interest

FMY

First Trust Motgage Income Fund of Beneficial Interest

HOLD

Current Price

$11.87

Market Cap

51.0M

Sector

Finance

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$5.02

Market Cap

60.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMY
NEPH
Founded
2005
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.0M
60.0M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
FMY
NEPH
Price
$11.87
$5.02
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
10.1K
74.6K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
6.98%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
N/A
$17,930,000.00
Revenue This Year
N/A
$33.32
Revenue Next Year
N/A
$12.27
P/E Ratio
N/A
$36.15
Revenue Growth
N/A
32.36
52 Week Low
$10.71
$1.39
52 Week High
$12.17
$6.42

Technical Indicators

Market Signals
Indicator
FMY
NEPH
Relative Strength Index (RSI) 37.39 48.33
Support Level $11.87 $4.83
Resistance Level $11.93 $5.97
Average True Range (ATR) 0.07 0.63
MACD -0.02 -0.03
Stochastic Oscillator 13.99 28.93

Price Performance

Historical Comparison
FMY
NEPH

About FMY First Trust Motgage Income Fund of Beneficial Interest

First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: